Assignee
NANOPHARMACEUTICALS LLC
US14 patents
Top patents by PatentIndex Score
US9579300B2Feb 28, 2017
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
NANOPHARMACEUTICALS LLC13 citations92
US10130686B2Nov 20, 2018
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
NANOPHARMACEUTICALS LLC7 citations84
US9498536B2Nov 22, 2016
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
NANOPHARMACEUTICALS LLC16 citations84
US9839614B2Dec 12, 2017
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
NANOPHARMACEUTICALS LLC9 citations83
US9750709B2Sep 5, 2017
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
NANOPHARMACEUTICALS LLC11 citations83
US10201616B2Feb 12, 2019
Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists
NANOPHARMACEUTICALS LLC6 citations82
US10328043B1Jun 25, 2019
Composition and method for dual targeting in treatment of neuroendocrine tumors
NANOPHARMACEUTICALS LLC11 citations79
US10961204B1Mar 30, 2021
Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
NANOPHARMACEUTICALS LLC4 citations73
US11077082B2Aug 3, 2021
Composition and method for dual targeting in treatment of neuroendocrine tumors
NANOPHARMACEUTICALS LLC2 citations68
US11186551B2Nov 30, 2021
Composition of scalable thyrointegrin antagonists with improved retention in tumors
NANOPHARMACEUTICALS LLC0 citations62
US11351137B2Jun 7, 2022
Composition and method for dual targeting in treatment of neuroendocrine tumors
NANOPHARMACEUTICALS LLC0 citations58
US11723888B2Aug 15, 2023
Polymer conjugated thyrointegrin antagonists
NANOPHARMACEUTICALS LLC0 citations56
US10695436B2Jun 30, 2020
Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonists
NANOPHARMACEUTICALS LLC0 citations50
US10060934B2Aug 28, 2018
Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof
NANOPHARMACEUTICALS LLC0 citations42